Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France.
Fiche publication
Date publication
janvier 2023
Journal
Cancer medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MAYNADIE Marc, Dr MOUNIER Morgane, Dr CHRETIEN Marie-Lorraine , Dr ROSSI Cédric
Tous les auteurs :
Atsou KM, Rachet B, Cornet E, Chretien ML, Rossi C, Remontet L, Roche L, Giorgi R, Gauthier S, Girard S, Böckle J, Wasse SK, Rachou H, Bouzid L, Poncet JM, Orazio S, Monnereau A, Troussard X, Mounier M, Maynadie M
Lien Pubmed
Résumé
The excess mortality observed in Acute Myeloblastic Leukaemia (AML) patients, partly attributed to unequal access to curative treatments, could be linked to care pathways.
Mots clés
acute myeloblastic leukaemia, care pathways, logistic regression, population-based data, specialised haematology unit access
Référence
Cancer Med. 2023 01 29;: